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(PDI) for ten of the plans, and by independent dose 
calculation checks using RadCalc (RadCalc Version 6.2, 
LifeLine Software Inc, Tyler, USA). 
 
Results: The observed differences between the conventional 
and the IMRT plans were limited. In average the maximum 
dose was 0.3 percentage points (pp) lower for IMRT than for 
conventional plans. The ITV coverage was better for the IMRT 
plans, with an average ITV minimum dose of 95.9 % compared 
to 94.1% (+1.8 pp). However, the PTV coverage was slightly 
worse for the IMRT plans, a decrease of 0.4 pp in V95%. The 
only relevant organs at risk are the lenses, were the 
maximum dose on average were lowered 0.3 Gray and the 
mean dose on average was lowered 0.1 Gray. The average HI 
for the IMRT plans was 4.0 while 5.1 for the conventional 
plans. The 10 PDI measurements were all accepted with a 
reference gamma index value of 5% dose agreement within 3 
mm distance to agreement, and no further measurements 
were performed. Independent dose calculation checks were 
performed for QA. The time spend on treatment planning was 
approximately 20 minutes for IMRT plans and could easily be 
up to 3 hours when using the conventional technique. 
 
 
Conclusion: It was possible to significantly reduce the time 
spend on dose planning by changing the treatment technique 
from conventional to IMRT for PCI patients while attaining 
comparable dosimetric quality of the treatment plans. 
Furthermore, both the treatment time and the time spend on 
quality assurances are comparable for the two techniques. 
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Purpose or Objective: To illustrate the technique and 
outcome of stereotactic body radiation therapy (SBRT) using 
Tomotherapy for refractory bone pain from metastatic 
disease. Tomotherapy SBRT planning parameters and 
dosimetric evaluation are outlined. 
 
Material and Methods: In 2013, a 70 year old female patient 
presented with metastatic non-small cell lung carcinoma, 
following resection of lung primary in 2012. CT and MRI 
confirmed a lytic lesion on right of sacrum. Patient’s sacrum 
initially treated with 30Gy/10Fx. Pain recurred 2 months post 
RT and managed by palliative care. 6 months post RT patient 
returned for consideration of re-treatment. Pain was 
refractory to everything apart from 15mg of oxycodone every 
hour. RO discussed the patient and risks of re-irradiation 
within the multidisciplinary setting. The consensus was to 
offer the patient SBRT, 24Gy in 3 fractions to the sacrum.  
Helical Tomotherapy was used to plan and treat patient. The 
irregular PTV volume was 201.12cm3. Dose volume 
constraints included: colon (0.035cc<18.4Gy, 20cc<14.3Gy), 
sacral plexus (0.035cc<11Gy, 5cc<7Gy), cauda equina 
(0.035cc<16Gy, 5cc<14Gy), and skin (0.035cc<26Gy, 
10cc<23Gy). No hotspots were to be located over the nerve 
roots. 
 
Results: Tomotherapy planning parameters included field 
width of 2.5cm, pitch of 0.2 and a modulation factor of 1.5. 
Beam on time was 400.3 seconds. PTV coverage statistics 
were D99 = 22.5Gy (93.75%), V95 = 98.57%, VTD = 90.53%, 
Median = 25.37Gy (105.71%), D1 = 27.8Gy (115.83%). OAR 
dose included colon 0.035cc = 8.1Gy, 20cc = 6.8Gy; sacral 
plexus 0.035cc = 27.3Gy, 5cc = 25.3Gy; cauda equina 0.035 = 
26.2Gy, 5cc = 21Gy; skin 0.035cc = 15.4Gy, 10cc = 12.3Gy. 
The conformity index statistics were R100% = 0.97, V105% 
outside PTV = 2cc, R50% = 4.21, Dmax > 2cm from PTV = 
16.45Gy (68.5%).  
One week post SBRT, patient’s pain stable and mobility 
improving. Whole body bone scan 2 months post SBRT showed 
decreased activity and size of sacral lesion. 4 months post 
SBRT patient returned with significant left sacral pain with 
concern of further metastatic disease. PET confirmed no 
uptake in left sacrum. Pain associated with insufficiency 
fracture with cause unknown, SBRT or bone metastasis likely 
contributors. 5 months post SBRT patient improved 
dramatically, completely ambulant with PET/CT showing no 
evidence of recurrence/metastatic disease. 13 months post 
SBRT, patient remains asymptomatic, CT shows no evidence 
of metastatic disease. 
 
Conclusion: This case study illustrates how the use SBRT can 
result in pain control for patients with refractory metastatic 
bone pain where there may be no other options available 
apart from palliative care, even in cases where the 
treatment volume is relatively large. This data is also 
informative since the patient shows no definite evidence of 
metastatic disease. Further studies could lead to improved 
therapies for the control of metastatic bone pain. 
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Purpose or Objective: Proton therapy cancer treatment 
offer potential clinical advantages compared with photon 
radiation therapy for many cancer sites. However, the 
treatment cost with proton is much higher than with 
conventional radiation. The objective of this study is to 
discuss how to improve a procedure, already described by 
others worldwide, to provide quantitative clues to select the 
patient for proton treatment instead of photon. 
 
Material and Methods: The respective medical and clinical 
benefits of proton and photon therapy are assessed by in 
silico comparison following four successive steps. First, the 
dosimetric analysis is made using parameters derived from 
dose volume histogram (DVH) for target volume and organs at 
risks. Second, the DVHs are exported from TPS to calculate 
TCP and mostly NTCP radiobiological indexes. In the third 
step, a statistical comparison is done using non-parametric 
test to calculate p-value, then bootstrap method is used to 
estimate the confidence intervals including the lower and 
upper limit of agreements. Then the correlation between 
data from proton and photon treatment planning is assessed 
using Spearman’s rank test. Finally, the cost-effectiveness 
and quality adjusted life years (QALYs) can be used to 
measures the outcome of the therapy and check if the 
therapeutic gain of proton therapy worth the increased 
expenses of it versus photon. 
 
Results: The results with in silico data can be taken into 
account to make a proposal of a decisional procedure. The 
dosimetric and radiobiological analysis can be used to check 
the medical benefit with either proton or photon. The 
statistical tests allow to check if the dosimetric or 
radiobiological benefits for a specific patient can be included 
in the confidence interval of agreement of a representative 
population, the most homogenous possible. A Markov model 
can be used to simulate the life of patients treated with 
proton / photon radiation. The virtual evaluation may 
indicate for which cancer sites proton therapy could be more 
cost-effective than photon therapy. 
 
Conclusion: The introduction of model based clinical trials 
with the possibility of individual assessment is a coming 
approach well adapted to the fast improvement of medical 
technology. The presently rising offer of proton therapy is a 
good example. The QALY concept based on objective 
dosimetric and clinical expected / modelized outcome may 
be a valuable response to this new challenge. However, large 
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cumulated medical data are needed to reduce steps by steps 
the uncertainties in the assumptions used in the present 
models. 
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Purpose or Objective: A single centre feasibility study to 
assess the reduction in sequential boost volume treated by 
rescanning patients during their final week of whole breast 
radiotherapy. 
 
Material and Methods: Patients requiring a sequential boost 
treatment who had a tumour bed seroma greater than 1cm 
on the initial radiotherapy planning (RTP) CT scan were 
considered for entry into the study.  
Thirty patients were sequentially recruited at the planning 
stage if they met this inclusion criteria. Patients were 
consented for entry into the trial and a second RTP CT scan 
(RTP 2) was conducted in their final week of whole breast 
radiotherapy. RTP 2 scan was used to determine the volume 
treated for their sequential boost.  
Both scans had the CTV outlined by the chief investigator and 
the CTV volume changes were annotated. 
 
Results: 83% of patients had a substantial reduction in CTV 
(>25%) in RTP 2 compared to RTP 1. The mean CTV reduction 
overall was 41.9% with a median reduction 42.5%. The mean 
time between scans was 27 days; median time 29 days. Mean 
time from start of whole breast radiotherapy treatment to 
RTP 2 was 14 days. 
 
Conclusion: This study shows that rescanning breast patients 
during the final week of whole breast radiotherapy leads to a 
significant decrease in treated boost volume in the majority 
of patients. 
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Purpose or Objective: Patients with spinal tumors have 
better outcomes with increased dose prescription. Due to the 
complex geometry of the treatment site and to the close 
proximity of the spinal cord, dose escalation is only possible 
with advanced techniques. This case study aims to determine 
if intensity-modulated radiation therapy (IMRT) could be a 
better option than dynamic conformal arc radiation therapy 
(DCA) for stereotactic spinal treatments. 
 
Material and Methods: Six patients previously treated with 
DCA were re-planned with IMRT. The same patient-specific 
criteria were followed in the new IMRT plan. Plan quality was 
compared by analyzing the dose-volume histogram (DVH) for 
the planning target volume (PTV) and for the spinal cord 
(SC). The conformity index (CI) and the monitor units (MU) 
number were also compared. 
 
Results: Both techniques provided adequate PTV coverage 
and SC sparing. Results favored IMRT in most of the analyzed 
PTV parameters: Dmax, D95, V95 and V100. DCA showed 
better results in PTV Dmin and D99 and had advantageous 
lower MU number. SC had superior dose sparing with IMRT 
plans. The CI was also improved by the IMRT technique. 
 
Conclusion: In general, IMRT plans proved to be a better 
planning solution, although with a significant higher number 
of MUs. IMRT treatments must be performed with higher 
accurate imaging guidance systems. 
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lesions using non-coplanar VMAT arcs 
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Purpose or Objective: To demonstrate the ability to include 
multiple lesions over the scalp, face and brain using non-
coplanar VMAT beams and a single isocentre 
73 yo man referred for post-op RT to mulitple scalp lesions, 
including bilateral spread to periauricular and parotid nodes. 
Diagnostic work up also showed an incidental right sided 
meningioma that was indicated for possible concurrent 
treatment.  
 
Material and Methods: The patient was scanned in a Klarity 
shell, on a Philips Big Bore CT. The dataset was imported into 
the TPS and diagnostic T1 and T2 MRI’s were fused for 
assisting in contouring.  
The scalp and bilateral periauricular and parotid regions were 
contoured as a single CTV and a 0.3cm PTV margin was 
added. The meningioma was contoured separately, also with 
a 0.3cm PTV margin applied.  
50.4Gy in 28 fractions was prescribed and the plan was 
generated in RayStation (v4.0.3) on an Elekta Synergy 
machine with 4° gantry spacing and a maximum delivery time 
of 90 seconds per beam. Two full transverse VMAT arcs were 
used with a partial sagittal arc added (floor at 270°). 
Isocentre placement was key due to potential collision risks. 
 
Results: Exceptional conformality was achieved. The 
introduction of the sagittal arc created a ring of dose around 
the skull providing excellent brain sparing as shown in Figure 
1. 
 
 
 
QA was perfomed using a 3D diode array with 99.6% pass rate 
at 3%/3mm criterion (6/1605 failed diodes). Absolute dose 
measurements were done using a pinpoint ionisation chamber 
inside both the scalp and meningioma PTVs indicating 
agreement with the TPS to within ±3.0%. 
XVI imaging was performed on fractions 1 to 3, then weekly, 
using grey scale match. Bony anatomy matched with <1° 
rotation. Treatment delivery averaged at 10 minutes making 
this beam arrangement extremely efficient to treat.  
Treatment was tolerated very well. Some changes to taste, 
dysphagia and mild to moderate xerostomia developed during 
the later stages of treatment. This was managed with general 
analgesia. There was no evidence of recurrence at three 
month follow up and the RO is now awaiting further 
diagnostic MRI's. 
 
Conclusion: Combining traditional transverse arcs with a 
partial non-coplanar arc is a safe and efficient technique to 
treat multiple head and neck volumes and provides 
exceptional sparing and dosimetric accuracy. The sagittal arc 
was integral to this conformal distribution over these 
complex PTV’s.  
 
 
